A study on clinico-immunologic response and virologic suppression rates of antiretroviral therapy in the treatment of naïve HIV-positive patients at a tertiary care hospital in Eastern India
Background: The tenofovir–lamivudine–efavirenz regimen was introduced in 2018, and there was a lack of data on the treatment trends in human immunodeficiency virus (HIV) patients in India. Therefore, we initiated this study. Objectives: Our objective was to evaluate the clinical and immunolog...
        Saved in:
      
    
          | Main Authors: | Madhuchhanda Mandal, Sabnam Parvin, Sonali Das | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Wolters Kluwer Medknow Publications
    
        2024-07-01 | 
| Series: | MGM Journal of Medical Sciences | 
| Subjects: | |
| Online Access: | https://journals.lww.com/mgmj/fulltext/2024/11030/a_study_on_clinico_immunologic_response_and.13.aspx | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV        
                          
 by: Zhenyan Wang, et al.
 Published: (2024-11-01)
- 
                
                    Incidence of opportunistic infections and its predictors among HIV/AIDS patients on antiretroviral therapy in Gondar University Comprehensive and Specialized Hospital, Ethiopia        
                          
 by: Mequanente Dagnaw, et al.
 Published: (2023-12-01)
- 
                
                    Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study        
                          
 by: Hernando Knobel, et al.
 Published: (2023-12-01)
- 
                
                    Time to antiretroviral therapy initiation 
in HIV-positive patients with opportunistic infections/AIDS-defining illness in Southern Thailand: a prospective cohort study        
                          
 by: Chanadda Wuttikul, et al.
 Published: (2024-04-01)
- 
                
                    The impact of adherence counseling incorporating a point of care urine tenofovir assay on virologic suppression among individuals failing tenofovir-lamivudine-dolutegravir: A pre-post intervention study        
                          
 by: Leonard Bikinesi, et al.
 Published: (2025-02-01)
 
       